ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Ferrovial SE

Ferrovial SE (FER)

48.66
0.28
(0.58%)
At close: 29 April 6:00AM
48.66
0.00
( 0.00% )
After Hours: 6:05AM

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
48.66
Bid
47.76
Offer
77.71
Volume
159,683
48.07 Day's Range 49.48
37.00 52 Week Range 56.43
Market Cap
Previous Close
48.38
Open
48.15
Last Trade
32
@
48.705
Last Trade Time
06:00:12
Financial Volume
US$ 7,739,262
VWAP
48.4664
Average Volume (3m)
100,865
Shares Outstanding
720,186,092
Dividend Yield
0.61%
PE Ratio
9.32
Earnings Per Share (EPS)
4.5
Revenue
9.16B
Net Profit
3.24B

About Ferrovial SE

Sector
Brdge,tunl,elvtd Hghwy Cnstr
Industry
Brdge,tunl,elvtd Hghwy Cnstr
Headquarters
Amsterdam, North Holland, Nld
Founded
-
Ferrovial SE is listed in the Brdge,tunl,elvtd Hghwy Cnstr sector of the NASDAQ with ticker FER. The last closing price for Ferrovial was US$48.38. Over the last year, Ferrovial shares have traded in a share price range of US$ 37.00 to US$ 56.43.

Ferrovial currently has 720,186,092 shares in issue. The market capitalisation of Ferrovial is US$34.84 billion. Ferrovial has a price to earnings ratio (PE ratio) of 9.32.

FER Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
12.445.2790999567346.2256.4344.4711862547.01730523CS
44.5310.265125764844.1356.4340.4613188644.73900423CS
127.2317.451122375141.4356.4340.4610086544.50354911CS
267.6718.711880946640.9956.4337.937591243.42139384CS
521.443.0495552731947.2256.43375390942.74108519CS
1561.443.0495552731947.2256.43375390942.74108519CS
2601.443.0495552731947.2256.43375390942.74108519CS

FER - Frequently Asked Questions (FAQ)

What is the current Ferrovial share price?
The current share price of Ferrovial is US$ 48.66
How many Ferrovial shares are in issue?
Ferrovial has 720,186,092 shares in issue
What is the market cap of Ferrovial?
The market capitalisation of Ferrovial is USD 34.84B
What is the 1 year trading range for Ferrovial share price?
Ferrovial has traded in the range of US$ 37.00 to US$ 56.43 during the past year
What is the PE ratio of Ferrovial?
The price to earnings ratio of Ferrovial is 9.32
What is the cash to sales ratio of Ferrovial?
The cash to sales ratio of Ferrovial is 3.29
What is the reporting currency for Ferrovial?
Ferrovial reports financial results in EUR
What is the latest annual turnover for Ferrovial?
The latest annual turnover of Ferrovial is EUR 9.16B
What is the latest annual profit for Ferrovial?
The latest annual profit of Ferrovial is EUR 3.24B
What is the registered address of Ferrovial?
The registered address for Ferrovial is GUSTAV MAHLERPLEIN, 61-63 SYMPHONY TOWERS, 14TH FLOOR, AMSTERDAM, NORTH HOLLAND, 1082 MS
What is the Ferrovial website address?
The website address for Ferrovial is www.ferrovial.com
Which industry sector does Ferrovial operate in?
Ferrovial operates in the BRDGE,TUNL,ELVTD HGHWY CNSTR sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PTLEPTL Ltd
US$ 1.82
(33.82%)
1.25M
WLDSWearable Devices Ltd
US$ 1.40
(16.72%)
29.41k
RNXTRenovoRx Inc
US$ 1.09
(12.14%)
1.77k
CTMXCytomX Therapeutics Inc
US$ 0.7887
(11.57%)
2.65M
VMEOVimeo Inc
US$ 5.50
(9.02%)
12.86k
FORAForian Inc
US$ 1.93
(-13.45%)
967
AVXLAnavex Life Sciences Corporation
US$ 8.3728
(-12.51%)
6.3k
PETWag Group Company
US$ 0.1448
(-12.14%)
509.93k
YMABY mAbs Therapeutics Inc
US$ 3.80
(-10.38%)
3.54k
SXTCChina SXT Pharmaceuticals Inc
US$ 2.30
(-9.80%)
15.86k
AGMHAGM Group Holdings Inc
US$ 0.121
(-7.70%)
12.76M
LGMKLogicMark Inc
US$ 0.01275
(0.39%)
3.41M
CTMXCytomX Therapeutics Inc
US$ 0.7887
(11.57%)
2.65M
LCIDLucid Group Inc
US$ 2.55
(0.99%)
2.37M
DMNDamon Inc
US$ 0.00375
(0.00%)
2.21M

Discussion

View Full Feed
imafan imafan 2 minutes ago
Eeyore has spoken! AKA professed lying short. Real News: HUUUUGE ANNOUNCEMENTS of HUUUUGE ACCOMPLISHMENTS IMMINENT!!! WHALES LURKING!!!
HHSE
StockItOut StockItOut 3 minutes ago
Another SmartyPants/Quester lie, or you have a filing to support your assertion?
XERI
fuagf fuagf 3 minutes ago
LOL Figured that comment would grab you. 🙃 Qualification to mine would be, of course, unless they had firm numbers wrapped up with more security than Fort Knox. While fully appreciating the gravity you see in the situation, and though I've read little lately, still am guessing it's better t
glenn1919 glenn1919 3 minutes ago
CTMX..............................................a/h
CTMX
dia76ca dia76ca 4 minutes ago
"Blarcamesine and Anavex 3-71 are changing the paradigm for the treatment of neurodegenerative and neurodevelopmental diseases."
Nice summary georgejjl !
Paradigm shifts are very exciting but some folks see them before others!
The rest of this year will be pivotal.
2026 s
AVXL
Lykiri Lykiri 4 minutes ago
Actually, there’s a bit of confusion here. Under the old regulation, both positive and negative recommendations were referred to the CHM for review. However, the new regulation (effective after 3 April 2025) stipulates that only applications with serious concerns are now referred to the CHM. Therefo
NWBO
I-Glow I-Glow 5 minutes ago
And the Hindenburg report.- https://hindenburgresearch.com/mullen/.

Plus, TenKay was all over the preferred shares and the financials.

IG
MULN
boi568 boi568 5 minutes ago
Even if an ADL "odds ratio" claim could normally be considered disqualifying in lieu of a comparison of the means, it just seems to me irrelevant to the EMA here, since ADL itself is a not ready for prime time EMA endpoint in an early AD trial.
AVXL
dennisdave dennisdave 5 minutes ago
I agree with your points . However there were medicines last year which got approved by MHRA but NICE decided not to get them covered by NHS same day or so. Those companies would have been in discussions with NICE before MHRA approval . So not really sure it is absolutely comforting Ok interesting
NWBO
hedge_fun hedge_fun 6 minutes ago
That’s what I said, you’re smarter than……

the markets.

In your opinion of course!
TSLA
WarMachine WarMachine 6 minutes ago
I couldn't imagine making such a fool of myself every day on a public forum.
You don't need to imagine it. LOL
they are beyond clueless about what's really happening here
Explain, IN DETAIL, with PROOF to validate your claims, EXACTLY what is going on here. Or is it YOU who is
MONI
Uncle Monkey Uncle Monkey 6 minutes ago
wow! huge MAGA action today. FSR

hahaha
CBRF
Natural Trader Natural Trader 7 minutes ago
it does with high PT
exwannabe exwannabe 7 minutes ago
Impossible, they have to by law. They cant simply stop discussion because NWBO "might" get refusal.
I do not claim to know how the MHRA-NICE communications work.

But I do think I understand the NICE process well enough. They are at hold waiting for the evidence submission. Ever
NWBO
Truenorth2016 Truenorth2016 7 minutes ago
Any Dip Before News IMO is a Golden Opportunity Set-up!!!
CAVR
skitahoe skitahoe 9 minutes ago
There have been many bashers here saying that NICE wouldn't even speak to the company, and it would be next year or later before they would be able to treat patients with payment from the UK healthcare system. It seems like they're very wrong and the system may be ready for patients very shortly af
NWBO
dennisdave dennisdave 9 minutes ago
so it's your belief Linda dares not to disclose negative material news Ofcourse she will but I think they will probably do that when there is no more escape route IF there is bad news to report. The 10K left them no option had they prior to that received bad news so I am pretty sure they didn't rece
NWBO
manibiotech manibiotech 9 minutes ago
I agree with your points . However there were medicines last year which got approved by MHRA but NICE decided not to get them covered by NHS same day or so. Those companies would have been in discussions with NICE before MHRA approval . So not really sure it is absolutely comforting . Looks like the
NWBO
fwb fwb 9 minutes ago
You have issues,
find a woman
Let her HELP YOU get RIGHT... if you know what I mean
PLTR
I-Glow I-Glow 9 minutes ago
I believe there is a caveat to that provision as the company also has to be Deficienct in another listing requirement.

TK, can explain it much better as well as others.

IG
MULN
ddls ddls 9 minutes ago
4/28/25, Buy: 525,000, Neutral: 4,076,000, Sell: 11,275,500

One last day buy ask slap trade to make this junk look good.
BIEL
archilles archilles 9 minutes ago
Isn’t there a newly graduated law student recently passed the bar exam lawyer who will take on this case for experience for small pro bono fees. This should be a relatively easy to identify the bad guys and the victims. What we have here are the victim shareholders, who got ripped off, versus the
ENZC